ANGELIQ 1 mg + 2 mg Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

angeliq 1 mg + 2 mg

bayer pharma ag - germania - combinatii (estradiolum + drospirenonum) - compr. film. - 1mg+2mg - combinatii de hormoni progestogeni si estrogeni progestative si estrogeni, combinatii fixe

Diane-35 0,035 mg/2 mg drajeuri Μολδαβία - Ρουμανικά - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

diane-35 0,035 mg/2 mg drajeuri

bayer ag - ethinylestradiolum + cyproteronum - drajeuri - 0,035 mg/2 mg

DIANE-35 0,035 mg/2,0 mg Ρουμανία - Ρουμανικά - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

diane-35 0,035 mg/2,0 mg

bayer pharma ag - combinatii - draj. - 0,035mg/2,0mg - antiandrogeni antiandrogeni si estrogeni

Diane-35 0,035 mg/2 mg drajeuri Μολδαβία - Ρουμανικά - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

diane-35 0,035 mg/2 mg drajeuri

bayer ag - ethinylestradiolum + cyproteronum - drajeuri - 0,035 mg/2 mg

Zoely 2,5 mg + 1,5 mg comprimate filmate Μολδαβία - Ρουμανικά - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

zoely 2,5 mg + 1,5 mg comprimate filmate

schering-plough central east ag - nomegestrolum + estradiolum - comprimate filmate - 2,5 mg + 1,5 mg

Midiana 3 mg/0,03 mg comprimate filmate Μολδαβία - Ρουμανικά - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

midiana 3 mg/0,03 mg comprimate filmate

gedeon richter plc - drospirenonum + ethinylestradiolum - comprimate filmate - 3 mg/0,03 mg

Dimia 3 mg/0,02 mg comprimate filmate Μολδαβία - Ρουμανικά - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

dimia 3 mg/0,02 mg comprimate filmate

gedeon richter plc - drospirenonum + ethinylestradiolum - comprimate filmate - 3 mg/0,02 mg

Dimia comprimate filmate 3 mg + 0,02 mg Μολδαβία - Ρουμανικά - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

dimia comprimate filmate 3 mg + 0,02 mg

gedeon richter plc - comprimate filmate - 3 mg + 0,02 mg

Tybost Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

tybost

gilead sciences ireland uc - cobicistat - infecții cu hiv - antivirale pentru uz sistemic - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.

Evotaz Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

evotaz

bristol-myers squibb pharma eeig - cobicistat, atazanavir - infecții cu hiv - antivirale pentru uz sistemic - evotaz is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1 infected adults and adolescents (aged 12 years and older weighing at least 35 kg) without known mutations associated with resistance to atazanavir (see sections 4. 4 și 5.